Position in ELAN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$273,367
-$56,795 QoQ
Shares Held
11,108
-19.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#339
of 515 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HB Wealth Management, LLC holds $9,010,122 across 12 Drug Manufacturers - Specialty & Generic names. ELAN ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
38,820 | $2,789,605 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2,331 | $1,263,005 | |
| 3 | HLN |
Haleon plc
|
133,227 | $1,243,007 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
7,323 | $1,234,218 | |
| 5 | VTRS |
Viatris Inc
|
58,985 | $936,681 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
8,693 | $294,518 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
19,136 | $277,280 | |
| 8 | ELAN |
Elanco Animal Health Inc
This page
|
11,108 | $273,367 |
All Filings in ELAN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $273,367 | 11,108 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $330,162 | 13,797 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $253,093 | 11,184 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $218,015 | 10,825 | Shares | Sole | 2025-10-23 | |
| No filing history on record for this holder in this stock. | ||||||